Here’s a story from Healthpoint Capital that suggests clinical trials for medical devices will soon be headed to India. The reason? Low participation and high costs in the U.S. and good clinical practices and a large, diverse population in India.

Companies stand to save 40 to 60%. Medtronic and Boston Scientific have already begun trials in India.

Read the story here.